Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer

Laryngoscope

Volumn 126, Issue 5, 2016, Pages 1097-1102

  Wang, Wen Lun ^a   Wang, Yu Chi ^a   Chang, Chi Yang ^a   Lo, Jo Lin ^a   Kuo, Yao Hung ^a   Hwang, Tzer Zen ^a   Wang, Chih Chun ^a   Mo, Lein Ray ^a   Lin, Jaw Town ^a,b,c   Lee, Ching Tai ^a  

^a I SHOU UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

esophageal cancer; field cancerization; head and neck cancer; Human papillomavirus; synchronous cancer

Indexed keywords

ALCOHOL; VIRUS DNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA SEQUENCE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; COMPLICATION; ESOPHAGUS TUMOR; FEMALE; HEAD AND NECK TUMOR; HUMAN PAPILLOMAVIRUS TYPE 16; MALE; MIDDLE AGED; MULTIPLE CANCER; ODDS RATIO; PAPILLOMAVIRIDAE; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL; VIROLOGY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA, VIRAL; ESOPHAGEAL NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84973537700     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.25728     Document Type: Article

References (42)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Taiwan Cancer Registry (1972-2010). Department of Health, Executive Yuan. Cancer Registry Annual Report. Available at: http://crs.cph.ntu.edu.tw. Accessed April 16, 2013
3. National Cancer Institute. Surveillance, Epidemiology, and End Results, SEER Cancer Statistics Review, 1975-2009. Available at: http://seer.cancer.gov/about/overview.html. Accessed April 16, 2013.
4. Slaughter DP, Southwick HW, Smejkal W,. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963-968.
5. Wang WL, Lee CT, Lee YC, et al., Risk factors for developing synchronous esophageal neoplasia in patients with head and neck cancer. Head Neck 2011; 33: 77-81.
6. Wang WL, Wang CP, Wang HP, et al., The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer. Oral Oncol 2013; 49: 808-813.
7. Lee CT, Chang CY, Lee YC, et al., Narrow-band imaging with magnifying endoscopy for the screening of esophageal cancer in patients with primary head and neck cancers. Endoscopy 2010; 42: 613-619.
8. Lee YC, Wang CP, Chen CC, et al., Transnasal endoscopy with narrow-band imaging and Lugol staining to screen patients with head and neck cancer whose condition limits oral intubation with standard endoscope (with video). Gastrointest Endosc 2009; 69: 408-417.
9. Cooper JS, Pajak TF, Rubin P, et al., Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989; 17: 449-456.
10. Liao L-J, Chou H-W, Wang C-T, Chung C-S, Lai M-S,. The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study. PLoS One 2013; 8: e62116.
11. Wang WL, Chang WL, Yeh YC, et al., Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract. Mol Carcinog 2013; 52: 438-445.
12. Muto M, Hironaka S, Nakane M, Boku N, Ohtsu A, Yoshida S,. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 2002; 56: 517-521.
13. Muto M, Takahashi M, Ohtsu A, Ebihara S, Yoshida S, Esumi H,. Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region. Carcinogenesis 2005; 26: 1008-1012.
14. Homann N, Karkkainen P, Koivisto T, Nosova T, Jokelainen K, Salaspuro M,. Effects of acetaldehyde on cell regeneration and differentiation of the upper gastrointestinal tract mucosa. J Natl Cancer Inst 1997; 89: 1692-1697.
15. van Houten VM, Snijders PJ, van den Brekel MW, et al., Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001; 93: 232-235.
16. Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT,. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002; 8: 3187-3192.
17. Gillison ML, Koch WM, Capone RB, et al., Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
18. He D, Zhang DK, Lam KY, et al., Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 1997; 72: 959-964.
19. Sur M, Cooper K,. The role of the human papilloma virus in esophageal cancer. Pathology 1998; 30: 348-354.
20. Dillner J, Knekt P, Schiller JT, Hakulinen T,. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. BMJ 1995; 311: 1346.
21. zur Hausen H,. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350.
22. Weinberger PM, Yu Z, Haffty BG, et al., Molecular classification identifies a subset of human papillomavirus-Associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-747.
23. Fakhry C, Westra WH, Li S, et al., Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
24. Ang KK, Harris J, Wheeler R, et al., Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
25. Yokoyama T, Yokoyama A, Kumagai Y, et al., Health risk appraisal models for mass screening of esophageal cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 2008; 17: 2846-2854.
26. Greene FL PD, Fleming ID, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002: 31-46 and 91-98.
27. Remmerbach TW, Brinckmann UG, Hemprich A, Chekol M, Kuhndel K, Liebert UG,. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol 2004; 30: 302-308.
28. Lin CY, Chao A, Yang YC, et al., Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. J Clin Virol 2008; 42: 361-367.
29. GenBank, NCBI,. Available from: http://blast.ncbi.nlm.nih.gov. Accessed January 22, 2013
30. Munger K, Scheffner M, Huibregtse JM, Howley PM,. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Cancer Surv 1992; 12: 197-217.
31. Pim D, Bergant M, Boon SS, et al., Human papillomaviruses and the specificity of PDZ domain targeting. FEBS J 2012; 279: 3530-3537.
32. Syrjanen K, Pyrhonen S, Aukee S, Koskela E,. Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol 1982; 5: 291-296.
33. Antonsson A, Nancarrow DJ, Brown IS, et al., High-risk human papillomavirus in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2010; 19: 2080-2087.
34. Califano J, Leong PL, Koch WM, Eisenberger CF, Sidransky D, Westra WH,. Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships. Clin Cancer Res 1999; 5: 1862-1867.
35. Chung KY, Mukhopadhyay T, Kim J, et al., Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993; 53: 1676-1683.
36. Visapaa JP, Gotte K, Benesova M, et al., Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C∗1 allele, possibly due to salivary acetaldehyde. Gut 2004; 53: 871-876.
37. Lee CH, Lee JM, Wu DC, et al., Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid. Int J Cancer 2008; 122: 1347-1356.
38. Gaudet MM, Olshan AF, Chuang SC, et al., Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Int J Epidemiol 2010; 39: 1091-1102.
39. Nieto A, Sanchez MJ, Martinez C, et al., Lifetime body mass index and risk of oral cavity and oropharyngeal cancer by smoking and drinking habits. Br J Cancer 2003; 89: 1667-1671.
40. Kreimer AR, Randi G, Herrero R, Castellsague X, La Vecchia C, Franceschi S,. Diet and body mass, and oral and oropharyngeal squamous cell carcinomas: analysis from the IARC multinational case-control study. Int J Cancer 2006; 118: 2293-2297.
41. Gaudet MM, Patel AV, Sun J, et al., Prospective studies of body mass index with head and neck cancer incidence and mortality. Cancer Epidemiol Biomarkers Prev 2012; 21: 497-503.
42. Hashibe M, Hunt J, Wei M, Buys S, Gren L, Lee YC,. Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort. Head Neck 2013; 35: 914-922.